ImportantArrangements for strategic, technical, manufacturing, or marketing tie up
Strides Pharma acquires and in-licenses multiple generic brands from Sandoz for an upfront consideration of approximately 99.6 Cr.
Strides Pharma Science LimitedSTAR · Filed with the exchange
This move strengthens Strides' Africa business, aiming for a top-five market position in Sub-Saharan Africa.
The portfolio includes products with individual annual sales exceeding 8.3 Cr.
No comments yet. Be the first.